Biosimilars Drug Research and Development
PPD Biosimilars Program Brings Your Drug To Market
PPD is at the forefront of biosimilar development and has the full expertise and dedicated team of professionals committed to support organizations of all sizes. Our experience spans a broad spectrum of therapeutic areas and services.
We supported development of all top 10 selling biological products and successfully delivered the first Monoclonal Antibody Biosimilar to the EU market.
We Understand the Biosimilar Process
Biosimilars represent a viable way to fill expanding pipeline gaps but also expand access to life-changing and life-saving therapies for patients by providing less expensive versions of already-marketed biologics. We offer a full range of biosimilar drug development services, from cell line development and characterization to clinical development and market approval.
Specialty Therapies and Biosimilars
Our biosimilar development services group ensures your program is fully integrated and streamlined in a way that results in maximum efficiencies and effectiveness. Our seamless development approach includes integrating structural and functional comparability assessments with the clinical program and regulatory submission strategy in a stepwise fashion to reduce residual uncertainty.